M2i Global and Volato are quietly assembling one of the more unconventional Wall Street stories of 2026: a critical‑minerals platform hitching a ride into the NYSE American via a technology‑driven private aviation company called SOAR.
A Billion‑Dollar Copper Anchor
M2i Global recently…
U.S. stocks pulled back on Wednesday, June 3, 2026, as investors digested fresh macro data, rising oil, and a crowded political and IPO calendar that includes California’s pivotal primary and the looming SpaceX roadshow.
Market wrap: risk-on pauses after records
Wall Street…
For years, the market treated “optics” as something you hired a PR team to fix, not a technology you built an AI empire on. Today, that view looks charmingly outdated as investors discover that the next leg of the artificial intelligence build‑out…
The market is rewarding platforms that promise to rewrite instructions rather than merely manage symptoms. Eli Lilly and Company (LLY) is teaming up with privately held Ascidian Therapeutics in a deal valued at up to $1.9 billion, giving Lilly exclusive, target-specific rights…
Wall Street has seen plenty of turnarounds, but not many that involve lingerie, Big Macs and a Bioceramic pocket watch. Investors, however, seem happy to fund all three. Victoria’s Secret & Co. (NYSE: VSXY) is suddenly back in fashion with the market,…
Palo Alto Networks (PANW) just delivered the kind of quarter that makes investors double‑check the ticker to ensure they’re not accidentally looking at a high‑growth SaaS darling disguised as a cybersecurity incumbent. Beneath the headline numbers, the story is a blend of…
US equities traded just below record highs on Tuesday, June 2, 2026, as an AI-fueled tech rally ran into profit-taking and persistent geopolitical and macro uncertainty ahead of a key jobs data week. AI infrastructure names, semis, and select consumer and casino…
America’s job market has finally come off the caffeine high—but it has not crashed the car. AI tech stocks are back in bull-market formation, investment bankers i.e. Goldman Sachs (GS) are openly using the phrase “greed mode,” and regulators just fired a…
Eupraxia Pharmaceuticals (EPRX) and Legend Biotech (LEGN) are quietly shaping one of Wall Street’s favorite narratives in 2026: niche innovators turning complex science into potentially durable revenue streams, with just enough volatility to keep the options desks awake.
Two Different Paths,…
Nvidia’s (NVDA) Jensen Huang just turned another chip maker into Wall Street’s latest trillion‑dollar daydream—and he did it with essentially four well‑placed words at Computex.
The Computex Moment: Four Words That Moved a Market
It is not every Monday morning in Taipei…
